T.-Y. Luh et al.
FULL PAPERS
3
3
Compound 1j: In a manner similar to that described for 1h, 16 (202 mg,
0.2 mmol) and 15 (98 mg, 0.6 mmol) were converted into 1j as a purple
solid (238 mg, 90%): m.p.: 118–1208C; 1H NMR (400 MHz, CDCl3): d=
ꢀ2.75 (s, 2H), 0.96 (t, 3J (H,H)=6.8 Hz, 9H), 1.37–1.68 (m, 32H), 1.92
(d, 3J (H,H)=6.8 Hz, 3H), 2.00 (quint, 3J (H,H)=6.8 Hz, 6H), 3.02 (br,
4H), 3.11–3.13 (m, 2H), 3.31–3.37 (m, 2H), 4.26 (t, 3J (H,H)=6.8 Hz,
6H), 5.62 (q, 3J (H,H)=6.8 Hz, 1H), 6.19 (s, 2H), 6.45 (d, 3J (H,H)=
8.8 Hz, 2H), 7.25–7.29 (m, 6H), 7.53 (d, 3J (H,H)=8.4 Hz, 2H), 8.03 (d,
3J (H,H)=8.4 Hz, 2H), 8.10 (d, 3J (H,H)=8.4 Hz, 6H), 8.20 (d, 3J
(H,H)=8.0 Hz, 2H), 8.81–8.87 ppm (m, 8H, b-H); 13C NMR (100 MHz,
CDCl3): d=14.3, 17.4, 22.8, 26.4, 29.4, 29.6, 29.8, 32.0, 45.4, 46.7, 50.5,
52.1, 68.3, 68.7, 110.9, 112.6, 115.1, 118.4, 119.5, 119.9, 120.0, 131.0, 131.6,
134.16, 134.22, 135.1, 135.4, 135.6, 139.9, 150.2, 150.5, 158.8, 166.3,
170.1 ppm; IR (KBr): n˜ =3316, 3031, 2923, 2847, 1780, 1708, 1606, 1511,
1498, 1467, 1377, 1343, 1274, 1249, 1172, 1100, 970, 802, 739 cmꢀ1; HRMS
(FAB): m/z: calcd for 1324.7466 (C87H98N5O7, [M++H]); found:
1324.7471.
2H), 7.68 (d, J (H,H)=8.8 Hz, 2H), 8.15 (d, J (H,H)=8.4 Hz, 6H), 8.26
(d, 3J (H,H)=8.0 Hz, 2H), 9.00 (d, 3J (H,H)=4.8 Hz, 2H; b-H), 9.04–
9.05 ppm (m, 6H; b-H); 13C NMR (100 MHz, CDCl3): d=14.6, 17.5, 23.1,
26.6, 29.65, 29.78, 29.80, 30.0, 32.2, 45.4, 46.7, 50.5, 52.2, 68.3, 68.5, 110.5,
112.3, 114.4, 119.1, 119.2, 120.3, 120.5, 120.7, 131.0, 131.2, 131.5, 131.7,
134.6, 134.7, 135.0, 135.3, 140.2, 149.5, 149.91, 149.94, 150.04, 158.0, 165.6,
169.4 ppm; IR (KBr): n˜ =3063, 3034, 2955, 2923, 2850, 1780, 1704, 1606,
1527, 1508, 1492, 1470, 1378, 1337, 1280, 1248, 1175, 1106, 998, 796, 770,
720 cmꢀ1; HRMS (FAB): m/z: calcd for 1385.6523 (C87H95N5O7Zn, [M+
]); found: 1385.6531.
Polymer 2d: A solution of 1d (79 mg, 0.06 mmol) and [(Cy3P)2Cl2Ru=
CHPh] (4.8 mg, 0.006 mmol) in CH2Cl2 (2 mL) was stirred under argon at
room temperature for 2 h. The mixture was quenched with ethyl vinyl
ether (0.2 mL) and then poured into MeOH (10 mL). The solid was col-
lected, redissolved in CH2Cl2 (1 mL), and reprecipitated by adding
MeOH (10 mL). This procedure was repeated twice, and the solid was
collected to afford 2d as a dark purple solid (79 mg, 99%); 1H NMR
(300 MHz, CDCl3): d=ꢀ2.85 (2H), 0.90 (s, 9H), 1.29–1.96 (m, 41H),
2.20–3.60 (m, 12H), 4.22 (s, 2H), 5.00–5.70 (m, 3H), 5.70–7.00 (m, 7H),
7.25 (s, 2H), 7.50–9.00 (m, 20H; phenyl and b-H), 10.01 ppm (br, 1H;
CONH); 13C NMR (100 MHz, CDCl3): d=14.1, 17.6, 22.7, 26.1, 29.3,
29.4, 31.8, 43–45 (br), 49–51 (br), 67.3, 68.2, 110–113 (br, embodied a
sharp peak at 112.6), 117–120 (br), 127–136 (br, embodied three sharp
peaks at 133.1, 134.4 and 135.5), 157.8, 158.9 ppm; IR (KBr): n˜ =3313,
2926, 2854, 1691, 1606, 1509, 1470, 1401, 1377, 1351, 1285, 1245, 1174,
1108, 966, 801, 735 cmꢀ1; GPC (THF): Mn =14820; Mw =16470; PDI=
1.11.
Compounds 1c and 1e: To a solution of 1d (132 mg, 0.1 mmol) in chloro-
form (30 mL) was added a methanolic solution (10 mL) of Zn acetate di-
hydrate (219 mg, 1 mmol), and the mixture was stirred at room tempera-
ture overnight, poured into water, and extracted with chloroform. The
chloroform extract was washed three times with water. The solvent was
evaporated and the residue was purified by column chromatography
(silica gel, CH2Cl2/CH3OH=100:1, v/v) to give a purple solid 1c (130 mg,
94%): m.p.: 156–1588C; 1H NMR (400 MHz, CDCl3): d=0.91 (t, 3J
(H,H)=6.4 Hz, 9H), 1.35–1.62 (m, 35H), 1.94 (quint, 3J (H,H)=6.4 Hz,
6H), 2.84 (d, 3J (H,H)=10.4 Hz, 2H), 2.94 (br, 2H), 3.00–3.01 (m, 2H),
3.12–3.17 (m, 2H), 4.00 (br, 1H; CHCO), 4.17–4.22 (m, 6H), 6.10 (s,
2H), 6.17–6.19 (m, 3H), 7.07 (d, 3J (H,H)=7.2 Hz, 2H), 7.17–7.28 (m,
2 f: (93%): GPC (THF): Mn =11460; Mw =12660; PDI=1.11.
2c: (96%): 1H NMR (300 MHz, CDCl3): d=0.93 (s, 9H), 1.30–1.96 (m,
41H), 2.20–3.60 (m, 8H), 4.22 (br, 6H), 5.00–6.00 (m, 3H), 6.00–7.26 (m,
9H), 7.27–7.50 (br, 2H), 7.60–8.40 (m, 10H), 8.40–9.50 ppm (m, 9H; b-H
and CONH); 13C NMR (100 MHz, CDCl3): d=14.2, 22.7, 26.2, 29.4, 29.5,
31.9, 35.3, 42–52 (v br), 67–69 (br), 110–114 (br), 119–121 (br), 128.6,
130–133 (br), 133–136 (br), 149–151 (br), 157–159 ppm (br); IR (KBr):
n˜ =2925, 2854, 1698, 1606, 1525, 1509, 1492, 1473, 1377, 1339, 1245, 1174,
1108, 1068, 998, 798, 719 cmꢀ1; GPC (THF): Mn =14190; Mw =16080;
PDI=1.13.
3
3
6H), 7.70 (d, J (H,H)=7.2 Hz, 2H), 8.03 (d, J (H,H)=8.0 Hz, 4H), 8.08
(d, 3J (H,H)=8.0 Hz, 4H), 8.75 (s, 1H), 8.90–8.94 ppm (m, 8H; b-H);
13C NMR (100 MHz, CDCl3): d=14.1, 17.1, 22.7, 26.2, 29.3, 29.5, 31.9,
45.3, 46.5, 49.2, 50.3, 52.0, 68.2, 110.7, 112.4, 117.6, 117.8, 120.2, 120.6,
120.7, 128.1, 131.7, 131.8, 134.8, 135.2, 135.3, 135.4, 135.7, 137.1, 138.7,
149.6, 150.1, 150.4, 150.5, 158.6, 167.3, 170.4 ppm; IR (KBr): n˜ =2926,
2854, 1698, 1606, 1525, 1509, 1493, 1473, 1378, 1339, 1245, 1174, 1108,
1068, 998, 797, 720 cmꢀ1; HRMS (MALDI): m/z, calcd for 1383.6850
(C87H97N7O5Zn, [M+]); found: 1383.6837.
2e: (95%): GPC (THF): Mn =13670; Mw =15440; PDI=1.13.
In a similar manner, reaction of 1 f (132 mg, 0.1 mmol) and a solution of
Zn acetate dihydrate (219 mg, 1 mmol) furnished 1e (125 mg, 91%) as a
purple solid: HRMS (MALDI): m/z: calcd for 1383.6862 (C87H97N7O5Zn,
[M+]); found: 1383.6837; elemental analysis calcd (%) for
C87H97N7O5Zn: C 75.38, H 7.05, N 7.07; found: C 74.95, H 7.20, N 7.00.
2h: (98%): 1H NMR (400 MHz, CDCl3): d=ꢀ2.76 (s, 2H), 0.88 (br,
9H), 1.28–1.90 (m, 41H), 2.37 (br, 4H), 2.91 (br, 4H), 3.81 (br, 4H), 4.11
(br, 2H), 5.09 (br, 2H), 5.58 (br, 1H), 6.30 (br, 2H), 6.87 (br, 4H), 7.15
(br, 2H), 7.50–8.20 (m, 12H), 8.50–8.80 ppm (m, 9H; NH and b-H);
13C NMR (100 MHz, CDCl3): d=14.1, 17.8, 22.7, 26.1, 26.9, 29.3, 31.8,
35.6, 36.9, 44.2, 46.1, 49.2, 68.2, 70.8, 111.5, 112.6, 115.7, 118.2, 119.0,
119.8, 131.6, 134.1, 134.9, 135.4, 137.0, 138.4, 151.1, 158.9, 165.9,
169.4 ppm; IR (KBr): n˜ =3420, 3316, 3028, 2920, 2847, 1704, 1606, 1525,
Compound 1g: In a manner similar to that described for 1c, 1h (132 mg,
0.1 mmol) was converted into 1g as a purple solid (126 mg, 91%): m.p.:
209–2118C; 1H NMR (400 MHz, CDCl3): d=1.00 (t, 3J (H,H)=6.8 Hz,
9H), 1.39–1.50 (m, 25H), 1.57–1.65 (m, 10H), 1.95 (quint, 3J (H,H)=
6.8 Hz, 6H), 2.84 (d, 3J (H,H)=10.4 Hz, 2H), 2.94–2.98 (m, 4H), 3.08–
3.15 (m, 2H), 4.14–4.19 (m, 6H), 4.83 (q, 3J (H,H)=6.8 Hz, 1H), 6.12 (s,
1507, 1470, 1375, 1347, 1277, 1239, 1169, 1096, 1030, 966, 799, 732 cmꢀ1
GPC (THF): Mn =17600; Mw =19300; PDI=1.09.
;
3
3
2H), 6.23 (d, J (H,H)=8.8 Hz, 2H), 7.22 (d, J (H,H)=8.8 Hz, 4H), 7.24
(d, 3J (H,H)=8.8 Hz, 2H), 7.58 (d, 3J (H,H)=8.0 Hz, 2H), 7.63 (d, 3J
(H,H)=8.8 Hz, 2H), 8.04 (s, 1H), 8.12 (d, 3J (H,H)=8.8 Hz, 4H), 8.15
(d, 3J (H,H)=8.0 Hz, 4H), 8.95 (d, 3J (H,H)=4.8 Hz, 2H; b-H), 9.01 (d,
3J (H,H)=4.8 Hz, 2H; b-H), 9.02 ppm (s, 4H; b-H); 13C NMR (100 MHz,
CDCl3): d=14.6, 17.8, 23.1, 26.6, 29.6, 29.8, 32.2, 45.4, 46.7, 50.5, 52.2,
68.3, 70.0, 110.6, 112.2, 114.0, 117.6, 119.6, 120.5, 120.6, 130.9, 131.2,
131.5, 134.4, 134.7, 135.0, 135.2, 135.8, 149.5, 149.9, 150.0, 150.1, 158.0,
164.7, 168.2 ppm; IR (KBr): n˜ =3417, 3329, 3031, 2925, 2851, 1704, 1679,
1603, 1524, 1508, 1489, 1467, 1381, 1338, 1270, 1239, 1169, 1090, 995, 796,
720 cmꢀ1; HRMS (FAB): m/z: calcd for 1384.6683 (C87H96N6O6, [M+]);
found: 1384.6677.
2g: (90%): 1H NMR (400 MHz, CDCl3): d=0.88 (br, 9H), 1.28–1.90 (m,
41H), 2.49 (br, 4H), 2.87 (br, 4H), 3.91 (br, 7H), 5.07 (br, 2H), 6.11 (br,
2H), 7.04 (br, 6H), 7.26–7.50 (m, 4H), 7.94 (br, 9H), 8.70–9.00 ppm (m,
8H; b-H); 13C NMR (100 MHz, CDCl3): d=14.1, 17.1, 22.7, 26.1, 29.4,
31.8, 35.3, 37.0, 44.2, 46.1, 49.2, 68.1, 69.9, 111.3, 112.5, 115.2, 117.7, 119.8,
120.7, 131.9, 134.8, 135.4, 139.3, 150.0, 150.5, 158.6, 165.3, 168.5 ppm; IR
(KBr): n˜ =3411, 3031, 2925, 2853, 1708, 1603, 1525, 1507, 1377, 1337,
1264, 1239, 1175, 1093, 995, 799, 717 cmꢀ1; GPC (THF): Mn =15500;
Mw =17400; PDI=1.12.
1
2j: (95%): H NMR (400 MHz, CDCl3): d=ꢀ2.76 (s, 2H), 0.91 (br, 9H),
1.28–1.90 (m, 41H), 2.56 (br, 4H), 3.11 (br, 4H), 3.94–4.20 (m, 6H), 5.16
(br, 2H), 5.52 (br, 1H), 6.41 (br, 2H), 7.02–7.26 (m, 6H), 7.41 (br, 2H),
7.80–8.00 (m, 10H), 8.68 ppm (br, 8H; b-H); 13C NMR (100 MHz,
CDCl3): d=14.3, 17.3, 22.8, 26.3, 29.4, 29.5, 29.6, 29.8, 32.0, 35.8, 36.2,
44.4, 46.4, 49.3, 68.1, 68.8, 111.3, 112.5, 115.8, 118.3, 119.5, 119.8, 120.0,
131.0, 131.6, 134.0, 135.1, 135.3, 139.8, 150.1, 150.9, 158.7, 166.1,
169.9 ppm; IR (KBr): n˜ =3313, 3028, 2930, 2851, 1770, 1708, 1603, 1511,
1473, 1372, 1343, 1274, 1242, 1176, 1100, 967, 802, 736 cmꢀ1; GPC (THF):
Mn =16490; Mw =19630; PDI=1.19.
Compound 1i: In a manner similar to that described for 1c, 1j (66 mg,
0.05 mmol) was transformed into 1i as a purple solid (67 mg, 97%): m.p.:
119–1208C; 1H NMR (400 MHz, CDCl3): d=1.02 (t, 3J (H,H)=6.8 Hz,
9H), 1.37–1.65 (m, 32H), 1.84 (d, 3J (H,H)=6.8 Hz, 3H), 1.91–1.99 (m,
6H), 2.85 (d, 3J (H,H)=11.2 Hz, 2H), 2.96 (br, 4H), 3.07–3.10 (m, 2H),
4.13–4.18 (m, 6H), 5.14 (q, 3J (H,H)=6.8 Hz, 1H), 6.15 (s, 2H), 6.22 (d,
3J (H,H)=8.8 Hz, 2H), 7.20–7.25 (m, 6H), 7.46 (d, 3J (H,H)=8.4 Hz,
1434
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Asian J. 2010, 5, 1425 – 1438